Protech Home Medical (CVE:PTQ) and Hamilton Thorne (CVE:HTL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations and institutional ownership.
Analyst Ratings
This is a summary of current recommendations for Protech Home Medical and Hamilton Thorne, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Protech Home Medical | 0 | 0 | 5 | 0 | 3.00 |
Hamilton Thorne | 0 | 0 | 4 | 0 | 3.00 |
Protech Home Medical presently has a consensus price target of C$2.58, indicating a potential upside of 21.28%. Hamilton Thorne has a consensus price target of C$1.87, indicating a potential upside of 6.86%. Given Protech Home Medical's higher possible upside, equities analysts plainly believe Protech Home Medical is more favorable than Hamilton Thorne.
Profitability
This table compares Protech Home Medical and Hamilton Thorne's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Protech Home Medical | N/A | N/A | N/A |
Hamilton Thorne | N/A | N/A | N/A |
Earnings and Valuation
This table compares Protech Home Medical and Hamilton Thorne's gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Protech Home Medical | C$82.22 million | 2.92 | C$-5,417,568.00 | C($0.05) | -44.38 |
Hamilton Thorne | C$39.78 million | 6.11 | C$1.25 million | C$0.01 | 194.44 |
Hamilton Thorne has lower revenue, but higher earnings than Protech Home Medical. Protech Home Medical is trading at a lower price-to-earnings ratio than Hamilton Thorne, indicating that it is currently the more affordable of the two stocks.
Summary
Hamilton Thorne beats Protech Home Medical on 4 of the 7 factors compared between the two stocks.